Peritonitis in Peritoneal Dialysis: Cited Facts and Guidelines

Introduction to Peritonitis Management

The American Journal of Kidney Diseases recommends avoiding aminoglucósidos in patients with residual renal function due to their potential nephrotoxicity 2, 3
The American Journal of Kidney Diseases suggests preserving residual renal function is crucial for outcomes in peritoneal dialysis patients 2, 3

The presence of cloudy dialysate is a cardinal sign of peritonitis in peritoneal dialysis patients 2
Abdominal pain is a common symptom of peritonitis in peritoneal dialysis patients 1
Fever may be present in some cases of peritonitis in peritoneal dialysis patients, but can also be absent 3

Praxis Medical Insights recommends a standard treatment duration of 2-3 weeks for peritonitis in peritoneal dialysis patients 1
The American Journal of Kidney Diseases suggests that the use of aminoglucósidos should be avoided when possible without compromising antibacterial efficacy due to their potential nephrotoxicity 2, 3

Praxis Medical Insights recommends catheter removal as almost always necessary for successful treatment of fungal peritonitis in peritoneal dialysis patients 1
Systemic treatment with amphotericin B or fluconazol is recommended for fungal peritonitis in peritoneal dialysis patients 1
Praxis Medical Insights advises against the use of intraperitoneal amphotericin B due to the risk of chemical peritonitis 1
Praxis Medical Insights recommends waiting at least 2 weeks after catheter removal before placing a new catheter in patients with fungal peritonitis 1
Treatment duration for fungal peritonitis should be guided by clinical response, typically 2-3 weeks 1